Search
Cardiovascular renal and metabolic diseases infographic
cardiometabolic_retinal_partner_interests.pdf
CardioMetabolic_diseases.pdf
Cardiometabolic_Diseases.pdf
CardioMetabolic_infographic_Update_2021.pdf
CardioMetabolic_Flyer_BIO_2022.pdf
Partnering_In_CARDIOMETABOLIC_0.pdf
Partnering in Cardiometabolic JAN 2023
Partnering in Cardiometabolic JAN 2023 Corporate
Cardio-Renal-Metabolic Infographic Update 2023
Partnering in Cardiometabolic Diseases MAY 2023 Corp
Partnering in Cardiometabolic Diseases MAY 2024 CORP_0.pdf
CardioMetabolic_infographic_FINAL Dec 18 V2.pdf
cardiometabolic_flyer_bio_2019.pdf
CardioMetabolic_Partnering_Interests_2018-12.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Catherine Alonzo
Catherine Alonzo, Patient Safety Physician, Metabolism, tells us about the importance of drug surveillance.
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
Discover your hidden talent with BI Open – the new platform for data science enthusiasts
Discover your hidden talent with BI Open – the new platform for data science enthusiasts. For more talent insights, visit our Careers Page.
Generalized pustular psoriasis: Value of community support
Dr Clerisme-Beaty and Dr Strober MD, PhD discuss the importance of knowledge sharing, community support and challenges faced by those living with GPP.
preserved-heart-failure-treatment-approval-europe
preserved-heart-failure-treatment-approval-europe
reduced-heart-failure-treatment-approval-europe
European approval for treatment of adults with heart failure with reduced ejection fraction
emperor-reduced-chmp-positive-opinion
CHMP issues positive opinion for the treatment of adults with heart failure with reduced ejection fraction
emperor-preserved-chmp-positive-opinion
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction